Literature DB >> 6181871

Combination chemotherapy with vincristine, carmustine, carmustine (BCNU), and bleomycin in patients with squamous cell bronchial carcinoma resistant to cyclophosphamide, doxorubicin, methotrexate, and procarbazine (CAMP).

A Veronesi, M D Magri, M G Trovò, U Tirelli, E Galligioni, S Tumolo, E Grigoletto.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6181871

Source DB:  PubMed          Journal:  Cancer Treat Rep        ISSN： 0361-5960


× No keyword cloud information.
  1 in total

1.  Phase II study of combination bleomycin, vincristine and high-dose methotrexate (BOM) with leucovorin rescue in advanced squamous cell carcinoma of the anal canal.

Authors:  N Wilking; N Petrelli; L Herrera; A Mittelman
Journal:  Cancer Chemother Pharmacol       Date:  1985       Impact factor: 3.333
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.